These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22024034)

  • 1. Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs.
    Uh E; Jackson ER; San Jose G; Maddox M; Lee RE; Lee RE; Boshoff HI; Dowd CS
    Bioorg Med Chem Lett; 2011 Dec; 21(23):6973-6. PubMed ID: 22024034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: an attempt to improve the activity against Mycobacterium tuberculosis.
    Andaloussi M; Lindh M; Björkelid C; Suresh S; Wieckowska A; Iyer H; Karlén A; Larhed M
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5403-7. PubMed ID: 21824775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and X-ray crystallographic studies of α-aryl substituted fosmidomycin analogues as inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
    Andaloussi M; Henriksson LM; Więckowska A; Lindh M; Björkelid C; Larsson AM; Suresh S; Iyer H; Srinivasa BR; Bergfors T; Unge T; Mowbray SL; Larhed M; Jones TA; Karlén A
    J Med Chem; 2011 Jul; 54(14):4964-76. PubMed ID: 21678907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (Dxr): a review of the synthesis and biological evaluation of recent inhibitors.
    Jackson ER; Dowd CS
    Curr Top Med Chem; 2012; 12(7):706-28. PubMed ID: 22283814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of chain length and unsaturation on Mtb Dxr inhibition and antitubercular killing activity of FR900098 analogs.
    Jackson ER; San Jose G; Brothers RC; Edelstein EK; Sheldon Z; Haymond A; Johny C; Boshoff HI; Couch RD; Dowd CS
    Bioorg Med Chem Lett; 2014 Jan; 24(2):649-53. PubMed ID: 24360562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of fosmidomycin analogs as inhibitors of the Synechocystis sp. PCC6803 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
    Woo YH; Fernandes RP; Proteau PJ
    Bioorg Med Chem; 2006 Apr; 14(7):2375-85. PubMed ID: 16310360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Activity Relationships of the MEPicides: N-Acyl and O-Linked Analogs of FR900098 as Inhibitors of Dxr from Mycobacterium tuberculosis and Yersinia pestis.
    San Jose G; Jackson ER; Haymond A; Johny C; Edwards RL; Wang X; Brothers RC; Edelstein EK; Odom AR; Boshoff HI; Couch RD; Dowd CS
    ACS Infect Dis; 2016 Dec; 2(12):923-935. PubMed ID: 27676224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of functionalized cinnamaldehyde derivatives by an oxidative Heck reaction and their use as starting materials for preparation of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors.
    Nordqvist A; Björkelid C; Andaloussi M; Jansson AM; Mowbray SL; Karlén A; Larhed M
    J Org Chem; 2011 Nov; 76(21):8986-98. PubMed ID: 21936546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordination chemistry based approach to lipophilic inhibitors of 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
    Deng L; Sundriyal S; Rubio V; Shi ZZ; Song Y
    J Med Chem; 2009 Nov; 52(21):6539-42. PubMed ID: 19888756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition of Mycobacterium smegmatis by prodrugs of deoxyxylulose phosphate reducto-isomerase inhibitors, promising anti-mycobacterial agents.
    Ponaire S; Zinglé C; Tritsch D; Grosdemange-Billiard C; Rohmer M
    Eur J Med Chem; 2012 May; 51():277-85. PubMed ID: 22405649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of in vitro antibacterial activity of fosmidomycin and its derivatives].
    Shtannikov AV; Sergeeva EE; Biketov SF; Ostrovskiĭ DN
    Antibiot Khimioter; 2007; 52(7-8):3-9. PubMed ID: 18986018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of alpha,beta-unsaturated alpha-aryl-substituted fosmidomycin analogues as DXR inhibitors.
    Devreux V; Wiesner J; Jomaa H; Van der Eycken J; Van Calenbergh S
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4920-3. PubMed ID: 17583502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies addressing the importance of charge in the binding of fosmidomycin-like molecules to deoxyxylulosephosphate reductoisomerase.
    Perruchon J; Ortmann R; Altenkämper M; Silber K; Wiesner J; Jomaa H; Klebe G; Schlitzer M
    ChemMedChem; 2008 Aug; 3(8):1232-41. PubMed ID: 18470849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse
    Abdullaziz MA; Takada S; Illarionov B; Pessanha de Carvalho L; Sakamoto Y; Höfmann S; Knak T; Kiffe-Delf AL; Mazzone F; Pfeffer K; Kalscheuer R; Bacher A; Held J; Fischer M; Tanaka N; Kurz T
    ACS Infect Dis; 2024 May; 10(5):1739-1752. PubMed ID: 38647213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to the antimicrobial agent fosmidomycin and an FR900098 prodrug through mutations in the deoxyxylulose phosphate reductoisomerase gene (dxr).
    Armstrong CM; Meyers DJ; Imlay LS; Freel Meyers C; Odom AR
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5511-9. PubMed ID: 26124156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-throughput screening assay for simultaneous selection of inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate synthase (Dxs) or 1-deoxy-D-xylulose 5-phosphate reductoisomerase (Dxr).
    Humnabadkar V; Jha RK; Ghatnekar N; De Sousa SM
    J Biomol Screen; 2011 Mar; 16(3):303-12. PubMed ID: 21335601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fragment-based approach to understanding inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
    Mercklé L; de Andrés-Gómez A; Dick B; Cox RJ; Godfrey CR
    Chembiochem; 2005 Oct; 6(10):1866-74. PubMed ID: 16116659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity.
    Wiesner J; Ortmann R; Jomaa H; Schlitzer M
    Arch Pharm (Weinheim); 2007 Dec; 340(12):667-9. PubMed ID: 17994601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase (IspC) from Mycobacterium tuberculosis: towards understanding mycobacterial resistance to fosmidomycin.
    Dhiman RK; Schaeffer ML; Bailey AM; Testa CA; Scherman H; Crick DC
    J Bacteriol; 2005 Dec; 187(24):8395-402. PubMed ID: 16321944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse fosmidomycin derivatives against the antimalarial drug target IspC (Dxr).
    Behrendt CT; Kunfermann A; Illarionova V; Matheeussen A; Pein MK; Gräwert T; Kaiser J; Bacher A; Eisenreich W; Illarionov B; Fischer M; Maes L; Groll M; Kurz T
    J Med Chem; 2011 Oct; 54(19):6796-802. PubMed ID: 21866890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.